Verition Fund Management
MEDP icon

Verition Fund Management’s Medpace MEDP Stock Holding History

Verition Fund Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,440
Closed -$3.57M – 2351
2026
Q1 		$3.57M Buy
7,440
+2,420
+48% +$1.24M 0.02% 724
2025
Q4 		$2.82M Sell
5,020
-11,257
-69% -$6.39M 0.01% 1306
2025
Q3 		$8.37M Buy
16,277
+10,504
+182% +$4.59M 0.03% 652
2025
Q2 		$1.81M Buy
5,773
+2,364
+69% +$710K 0.01% 2029
2025
Q1 		$1.04M Buy
3,409
+1,532
+82% +$515K ﹤0.01% 2101
2024
Q4 		$624K Buy
+1,877
New +$637K ﹤0.01% 2340
2024
Q3 		– Sell
-2,276
Closed -$937K – 3401
2024
Q2 		$937K Buy
2,276
+1,385
+155% +$548K 0.01% 1716
2024
Q1 		$360K Buy
+891
New +$313K ﹤0.01% 2194
2023
Q3 		– Sell
-6,435
Closed -$1.55M – 2538
2023
Q2 		$1.55M Buy
6,435
+4,543
+240% +$944K 0.02% 789
2023
Q1 		$356K Buy
+1,892
New +$391K ﹤0.01% 1415
2018
Q4 		– Sell
-25,873
Closed -$1.55M – 1090
2018
Q3 		$1.55M Buy
+25,873
New +$1.42M 0.06% 397

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Verition Fund Management's MEDP Position: Q2 2026 in Review

Verition Fund Management sold out of Medpace (MEDP) in Q2 2026, closing a stake of 7,440 shares — an estimated $3.57M sold.

Verition Fund Management first reported a position in MEDP in Q3 2018 and held it in 11 quarters. The position peaked at $8.37M in Q3 2025. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Verition Fund Management reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 7,440 Medpace shares in Q2 2026, an estimated $3.57M.
  • Verition Fund Management first reported a position in Medpace in Q3 2018 and held it in 11 quarters.
  • Verition Fund Management's Medpace position peaked at $8.37M in Q3 2025.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.